News | July 04, 2023
Adare Pharma divests Adare Biome to dsm-firmenich
The transaction represents an enterprise value of €275 million, an estimated 2023 EV/EBITDA multiple of 18x
The transaction represents an enterprise value of €275 million, an estimated 2023 EV/EBITDA multiple of 18x
Dignitaries and delegates commend India’s leadership in Global South during G20 India Presidency
Panacea Biotec has announced the launch of its new range of high-quality pediatric food & nutritional products
Under the terms of the VPPA, IGNIS will produce renewable energy equal to Lonza’s electricity needs across Switzerland and the European Union.
The new Biolys provides higher concentration of L-lysine
Debut Biotechnology has outstanding enzyme search and design technology and a bio-manufacturing platform (precision fermentation, cell-free synthesis) using those enzymes
One thousand times more soluble than L-cystine at neutral pH
Wider reach for nutraceuticals portfolio in Europe, Turkey and Egypt
The acquisition of ADL BioPharma now makes WACKER owner of the entire plant, with total fermentation capacities of just under 3,000 cubic meters
The collaboration between CORONA and Ferring will cater to patients across India
Subscribe To Our Newsletter & Stay Updated
